ResearcherShenyang Pharmaceutical UniversityNo recent work listed

Chao Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1142-8128; OpenAlex author ID A5100661295. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2020: 1 paper

Papers 1

Licocoumarone induces BxPC-3 pancreatic adenocarcinoma cell death by inhibiting DYRK1A. Co-author DOI 10.1016/j.cbi.2019.108913 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hua Li · 1 shared paper, 2020 · strength 0.13
- Paper Licocoumarone induces BxPC-3 pancreatic adenocarcinoma cell death by inhibiting DYRK1A. DOI 10.1016/j.cbi.2019.108913 ↗
Lixia Chen · 1 shared paper, 2020 · strength 0.13
- Paper Licocoumarone induces BxPC-3 pancreatic adenocarcinoma cell death by inhibiting DYRK1A. DOI 10.1016/j.cbi.2019.108913 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.